{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:35:27Z","timestamp":1771054527961,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.neulet.2012.04.079","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T22:05:49Z","timestamp":1336514749000},"page":"78-84","source":"Crossref","is-referenced-by-count":16,"title":["Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy"],"prefix":"10.1016","volume":"527","author":[{"given":"Deirdre M.","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas M.","family":"Boulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2012.04.079_bib0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuron.2011.05.007","article-title":"Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta Stone","volume":"70","author":"Aboody","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2012.04.079_bib0010","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","article-title":"Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy","volume":"114","author":"Azzouz","year":"2004","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.neulet.2012.04.079_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2012.04.079_bib0020","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"Bevan","year":"2011","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/rej.2011.1197","article-title":"Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration","volume":"14","author":"Bigini","year":"2011","journal-title":"Rejuvenation Research"},{"key":"10.1016\/j.neulet.2012.04.079_bib0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.nbd.2003.08.025","article-title":"Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery","volume":"14","author":"Boulis","year":"2003","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.neulet.2012.04.079_bib0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00006123-199907000-00029","article-title":"Characterization of adenoviral gene expression in spinal cord after remote vector delivery","volume":"45","author":"Boulis","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neulet.2012.04.079_bib0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajhg.2008.12.010","article-title":"Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS","volume":"84","author":"Chow","year":"2009","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.neulet.2012.04.079_bib0050","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1172\/JCI35432","article-title":"Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy","volume":"118","author":"Corti","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.neulet.2012.04.079_bib0055","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1093\/hmg\/ddq293","article-title":"Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis","volume":"19","author":"Corti","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.neulet.2012.04.079_bib0060","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neulet.2012.04.079_bib0065","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mt.2008.60","article-title":"Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity","volume":"16","author":"Dodge","year":"2008","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrd3000","article-title":"Human stem cells and drug screening: opportunities and challenges","volume":"9","author":"Ebert","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.neulet.2012.04.079_bib0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mus.20439","article-title":"Gene-based treatment of motor neuron diseases","volume":"33","author":"Federici","year":"2006","journal-title":"Muscle and Nerve"},{"key":"10.1016\/j.neulet.2012.04.079_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-0556-7-1","article-title":"Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer","volume":"7","author":"Federici","year":"2009","journal-title":"Genet Vaccines Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0085","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1016\/j.ymthe.2005.07.398","article-title":"In vivo spinal cord uptake and neuronal binding properties of Tet1: A potential means for enhanced spinal cord AAV delivery","volume":"11","author":"Federici","year":"2005","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0090","series-title":"ASGCT 14th Annual Meeting, vol. 19","first-page":"S250","article-title":"Robust motor neuron transduction following intrathecal delivery of AAV9.GFP to pigs","author":"Federici","year":"2011"},{"key":"10.1016\/j.neulet.2012.04.079_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/hum.1992.3.1-11","article-title":"In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer","volume":"3","author":"Fink","year":"1992","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0100","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3109\/14653249.2011.592521","article-title":"Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis","volume":"13","author":"Forostyak","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.neulet.2012.04.079_bib0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.neulet.2012.04.079_bib0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2008.12.003","article-title":"Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS","volume":"33","author":"Franz","year":"2009","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.neulet.2012.04.079_bib0120","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/stem.1079","article-title":"Lumbar intraspinal injection of neural stem cells in patients with ALS: Results of a phase I trial in 12 patients","volume":"30","author":"Glass","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.neulet.2012.04.079_bib0125","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Molecular Therpy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1742","article-title":"ANG mutations segregate with familial and \u2018sporadic\u2019 amyotrophic lateral sclerosis","volume":"38","author":"Greenway","year":"2006","journal-title":"Nature Genetics"},{"key":"10.1016\/j.neulet.2012.04.079_bib0135","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.neulet.2012.04.079_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-7799(99)01396-7","article-title":"Cells for tissue engineering","volume":"18","author":"Heath","year":"2000","journal-title":"Trends in Biotechnology"},{"key":"10.1016\/j.neulet.2012.04.079_bib0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/mt.2010.271","article-title":"CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit","volume":"19","author":"Henriques","year":"2011","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0150","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neulet.2012.04.079_bib0155","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.neulet.2012.04.079_bib0160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neulet.2012.04.079_bib0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000331327","article-title":"Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"9","author":"Knippenberg","year":"2012","journal-title":"Neurodegenerative Diseases"},{"key":"10.1016\/j.neulet.2012.04.079_bib0170","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neulet.2012.04.079_bib0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2012.04.079_bib0180","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/hmg\/ddg143","article-title":"Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy","volume":"12","author":"Lesbordes","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.neulet.2012.04.079_bib0185","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1128\/JVI.75.9.4343-4356.2001","article-title":"Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo","volume":"75","author":"Lilley","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.neulet.2012.04.079_bib0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/rme.11.6","article-title":"Stem cell technology for the study and treatment of motor neuron diseases","volume":"6","author":"Lunn","year":"2011","journal-title":"Regenerative Medicine"},{"key":"10.1016\/j.neulet.2012.04.079_bib0195","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","article-title":"Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery","volume":"10","author":"Mazarakis","year":"2001","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.neulet.2012.04.079_bib0200","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3858\/emm.2009.41.7.054","article-title":"Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice","volume":"41","author":"Park","year":"2009","journal-title":"Experimental and Molecular Medicine"},{"key":"10.1016\/j.neulet.2012.04.079_bib0205","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.expneurol.2005.04.018","article-title":"Expression profile of an operationally-defined neural stem cell clone","volume":"194","author":"Parker","year":"2005","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neulet.2012.04.079_bib0210","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.neulet.2012.04.079_bib0215","series-title":"Comparative Effects between Bone Marrow and Mesenchymal Stem Cell Transplantation in GDNF Expression and Motor Function Recovery in a Motorneuron Degenerative Mouse Model","author":"Pastor","year":"2011"},{"key":"10.1016\/j.neulet.2012.04.079_bib0220","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.gt.3302258","article-title":"Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo","volume":"11","author":"Perez","year":"2004","journal-title":"Gene Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1205","article-title":"Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model","volume":"11","author":"Ralph","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/j.neulet.2012.04.079_bib0230","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1097\/BRS.0b013e3181d77a47","article-title":"Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs","volume":"36","author":"Raore","year":"2011","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.neulet.2012.04.079_bib0235","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1097\/BRS.0b013e3181d77a47","article-title":"Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs","volume":"36","author":"Raore","year":"2011","journal-title":"Spine"},{"key":"10.1016\/j.neulet.2012.04.079_bib0240","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.neulet.2012.04.079_bib0245","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1227\/01.NEU.0000343524.45387.9E","article-title":"Cervical Spinal Cord Therapeutic Delivery: Preclinical Safety Validation of a Stabilized Microinjection Platform","volume":"65","author":"Riley","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neulet.2012.04.079_bib0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1089\/hum.2011.200","article-title":"Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates","volume":"23","author":"Samaranch","year":"2012","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0255","series-title":"Comparison of Adeno-Associated Viral Vector Serotypes for Spinal Cord and Motor Neuron Gene Delivery","author":"Snyder","year":"2011"},{"key":"10.1016\/j.neulet.2012.04.079_bib0260","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neulet.2012.04.079_bib0265","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.gt.3302071","article-title":"Gene therapy progress and prospects: adenoviral vectors","volume":"10","author":"St George","year":"2003","journal-title":"Gene Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0270","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2012.04.079_bib0275","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S1525-0016(16)40688-X","article-title":"Techniques for remote cervical spinal cord delivery of neurotherapeutic RabG-EIAV encoded genes","volume":"7","author":"Tanase","year":"2003","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.neulet.2012.04.079_bib0280","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.nbd.2011.06.021","article-title":"IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice","volume":"45","author":"Tsai","year":"2012","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.neulet.2012.04.079_bib0285","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/eji.200636416","article-title":"Immunoregulatory function of mesenchymal stem cells","volume":"36","author":"Uccelli","year":"2006","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.neulet.2012.04.079_bib0290","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3727\/096368910X503406","article-title":"Analysis of dosing regimen and reproducibility of intraspinal grafting of human spinal stem cells in immunosuppressed minipigs","volume":"19","author":"Usvald","year":"2010","journal-title":"Cell Transplantation"},{"key":"10.1016\/j.neulet.2012.04.079_bib0295","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neulet.2012.04.079_bib0300","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","article-title":"Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Vercelli","year":"2008","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.neulet.2012.04.079_bib0305","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.22-16-06920.2002","article-title":"Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis","volume":"22","author":"Wang","year":"2002","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neulet.2012.04.079_bib0310","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","article-title":"Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats","volume":"82","author":"Xu","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.neulet.2012.04.079_bib0315","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/mt.2011.98","article-title":"Several rAAV vectors efficiently cross the blood\u2013brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system","volume":"19","author":"Zhang","year":"2011","journal-title":"Molecular Therapy: The Journal of the American Society of Gene Therapy"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394012006350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394012006350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T11:58:45Z","timestamp":1561723125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394012006350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0304394012006350"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2012.04.079","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}